Adaptation of a Values Assessment Tool

Launched by UNC LINEBERGER COMPREHENSIVE CANCER CENTER · Jul 6, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at a new tool designed to help women with metastatic breast cancer—and their caregivers—when making important decisions about their care. The tool aims to make it easier for patients and their families to understand their options and communicate better with their cancer doctors, hopefully reducing the stress and confusion that can come with these tough choices.

Women who are 18 years or older, have metastatic breast cancer, can read and understand English, and receive treatment at the North Carolina Cancer Hospital or its community clinics may be eligible to join. Participants will be asked to use this values assessment tool and share their experiences with it during their care. It’s important to note that women who cannot provide consent, communicate verbally, understand English, or who are currently in hospice care are not eligible. This study is currently recruiting, and taking part could help improve how patients and doctors talk about treatment decisions in the future.

Gender

FEMALE

Eligibility criteria

• • Inclusion Criteria
• • 1. Age ≥18 years
• • 2. Diagnosed with metastatic breast cancer.
• • 3. Understand and read English.
• • 4. Receive care or anticipate receiving care at the North Carolina Cancer Hospital ambulatory cancer clinic or affiliated community cancer clinic.
• • 5. Able to understand and participate in study procedures for length of study.
• • Exclusion Criteria
• 1. All subjects meeting any of the exclusion criteria at baseline will be excluded from study participation:
• • 2. Unable to provide consent, unable to communicate verbally.
• • 3. Unable to understand or read English.
• • 4. Enrolled in hospice care.